Work

Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice

Year: 2004

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-04-0096

Authors: Clinton F. Stewart, Markos Leggas, John D. Schuetz, John C. Panetta, Pamela J. Cheshire, Jennifer Peterson, Najat Daw, Jesse J. Jenkins, Richard Gilbertson, Glen S. Germain, Franklin C. Harwood, Peter J. Houghton

Institution: St. Jude Children's Research Hospital

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1139922818, MTOR as a Therapeutic Target in Childhood Cancer, G2499473270, Studies of Childhood Solid Tumors, Rapamycin-Induced Selective Apoptosis in Malignant Cells, G609259107, Cancer Center Support Grant (CCSG), G916274158

OpenAlex ID: W2156609950

FWCI: 7.488

Cites: 46

Cited by: 203

Related to: 10